Also, a novel clinical predictive model was established, incorporating five FA-related signatures (BRIP1, FANCC, FANCL, MAD2L2, and RFWD3) for patients diagnosed with AML. The gene discussed is MAD2L2; the disease is acute myeloid leukemia.